JBM  Vol.7 No.7 , July 2019
Fatty Acid Binding Protein-4 Silencing Attenuates Atherosclerosis Progression by Affecting Macrophage Apoptosis and Autophagy
Abstract: Background: Atherosclerosis, which is the principal cause of heart attacks and strokes, is the leading cause of death in the United States. Various biological processes such as apoptosis and autophagy are involved in almost every stage of atherosclerosis, which could lead to plaque instability causing stroke and death. Fatty Acid Binding Protein 4 (FABP4) is an adipokine released by macrophages and is involved in multiple disease conditions including stroke. However, the association of FABP4 with macrophage apoptosis and autophagy in atherosclerosis has not been elucidated. We hypothesize that silencing FABP4 protein could be a novel therapeutic approach to attenuate macrophage apoptosis and autophagy thereby minimizing plaque instability in atherosclerosis. Methods: RAW264 mouse macrophage cells were transfected with siRNA control liposome quantum dots (QD), siFABP4 liposome QD at the concentration of 150 μg/ml total lipids, or TNF-α at 100 ng/ml. Western blot and reverse phase protein array (RPPA) analysis were completed. Results: Inhibiting the translation of FABP4 blocked the apoptotic pathway as evidenced from the increased expression of anti-apoptotic BCL-xL and BCL-2 along with reduced expression of BAX and activated Caspase 3 levels. Beclin-1 and LC3-II levels were also reduced with knocking down FABP4 indicating the attenuation of autophagy. Conclusion: Targeting FABP4 protects against macrophage processes associated with the progression of atherosclerosis.
Cite this paper: Zhaorigetu, S. , Prathipati, P. , Rodriguez-Aguayo, C. , Walton, B. , Sood, A. , Berestein-Lopez, G. (2019) Fatty Acid Binding Protein-4 Silencing Attenuates Atherosclerosis Progression by Affecting Macrophage Apoptosis and Autophagy. Journal of Biosciences and Medicines, 7, 99-109. doi: 10.4236/jbm.2019.77008.

[1]   Weber, C. and Noels, H. (2011) Atherosclerosis: Current Pathogenesis and Therapeutic Options. Nature Medicine, 17, 1410-1422.

[2]   Hansson, G.K. (2005) Inflammation, Atherosclerosis, and Coronary Artery Disease. The New England Journal of Medicine, 352, 1685-1695.

[3]   Halvorsen, B., Otterdal, K., Dahl, T.B., Skjelland, M., Gullestad, L., et al. (2008) Atherosclerotic Plaque Stability—What Determines the Fate of a Plaque? Progress in Cardiovascular Diseases, 51, 183-194.

[4]   Tabas, I. (2009) Macrophage Apoptosis in Atherosclerosis: Consequences on Plaque Progression and the Role of Endoplasmic Reticulum Stress. Antioxidants & Redox Signaling, 11, 2333-2339.

[5]   Rubinsztein, D.C., Marino, G. and Kroemer, G. (2011) Autophagy and Aging. Cell, 146, 682-695.

[6]   Sergin, I., Evans, T.D., Zhang, X.Y., Bhattacharya, S., et al. (2017) Exploiting Macrophage Autophagy-Lysosomal Biogenesis as a Therapy for Atherosclerosis. Nature Communications, 8, Article No. 15750.

[7]   Djousse, L. and Gaziano, J.M. (2012) Plasma Levels of FABP4, But Not FABP3, Are Associated with Increased Risk of Diabetes. Lipids, 47, 757-762.

[8]   Liu, G., Ding, M., Chiuve, S.E., Rimm, E.B., Franks, P.W., et al. (2016) Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality among Men with Type 2 Diabetes: A 22-Year Prospective Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 36, 2259-2267.

[9]   Doi, M., Miyoshi, T., Hirohata, S., Nakamura, K., Usui, S., et al. (2011) Association of Increased Plasma Adipocyte Fatty Acid-Binding Protein with Coronary Artery Disease in Non-Elderly Men. Cardiovascular Diabetology, 10, 44.

[10]   Kralisch, S. and Fasshauer, M. (2013) Adipocyte Fatty Acid Binding Protein: A Novel Adipokine Involved in the Pathogenesis of Metabolic and Vascular Disease? Diabetologia, 56, 10-21.

[11]   Makowski, L., Boord, J.B., Maeda, K., Babaev, V.R., Uysal, K.T., et al. (2001) Lack of Macrophage Fatty-Acid-Binding Protein aP2 Protects Mice Deficient in Apolipoprotein E against Atherosclerosis. Nature Medicine, 7, 699-705.

[12]   Boord, J.B., Maeda, K., Makowski, L., Babaev, V.R., Fazio, S., et al. (2002) Adipocyte Fatty Acid-Binding Protein, aP2, Alters Late Atherosclerotic Lesion Formation in Severe Hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 1686-1691.

[13]   Furuhashi, M., Tuncman, G., Görgün, C.Z., Makowski, L., Atsumi, G., et al. (2007) Treatment of Diabetes and Atherosclerosis by Inhibiting Fatty-Acid-Binding Protein aP2. Nature, 447, 959-965.

[14]   Kim, D. and Rossi, J. (2008) RNAi Mechanisms and Applications. Biotechniques, 44, 613-616.

[15]   Bulbake, U., Doppalapudi, S., Kommineni, N. and Khan, W. (2017) Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics, 9, pii: E12.

[16]   Sakurai, H., Kawabata, K., Sakurai, F., Nakagawa, S. and Mizuguchi, H. (2008) Innate Immune Response Induced by Gene Delivery Vectors. International Journal of Pharmaceutics, 354, 9-15.

[17]   Walton, B.L., Leja, M., Vickers, K.C., Estevez-Fernandez, M., Sanguino, A., Wang, E., et al. (2010) Delivery of Negatively Charged Liposomes into the Atheromas of Watanabe Heritable Hyperlipidemic Rabbits. Vascular Medicine, 15, 307-313.

[18]   Martinet, W. and De Meyer, G.R. (2008) Autophagy in Atherosclerosis. Current Atherosclerosis Reports, 10, 216-223.

[19]   Libby, P., Ridker, P.M. and Hansson, G.K. (2011) Progress and Challenges in Translating the Biology of Atherosclerosis. Nature, 473, 317-325.

[20]   Moore, K.J., Sheedy, F.J. and Fisher, E.A. (2013) Macrophages in Atherosclerosis: A Dynamic Balance. Nature Reviews Immunology, 13, 709-721.

[21]   Moore, K.J. and Tabas, I. (2011) Macrophages in the Pathogenesis of Atherosclerosis. Cell, 145, 341-355.

[22]   Tu, W.J., Zeng, X.-W., Deng, A.J., Zhao, S.-J., Luo, D.-Z., et al. (2017) Circulating FABP4 (Fatty Acid-Binding Protein 4) Is a Novel Prognostic Biomarker in Patients with Acute Ischemic Stroke. Stroke, 48, 1531-1538.

[23]   Erbay, E., Babaev, V.R., Mayers, J.R., Makowski, L., Charles, K.N., et al. (2009) Reducing Endoplasmic Reticulum Stress through a Macrophage Lipid Chaperone Alleviates Atherosclerosis. Nature Medicine, 15, 1383-1391.

[24]   Yao, F., Li, Z., Eharad, T., Yang, L., Wang, D.D., et al. (2015) Fatty Acid-Binding Protein 4 Mediates Apoptosis via Endoplasmic Reticulum Stress in Mesangial Cells of Diabetic Nephropathy. Molecular and Cellular Endocrinology, 411, 232-242.

[25]   Murray, P.J. and Wynn, T.A. (2011) Protective and Pathogenic Functions of Macrophage Subsets. Nature Reviews Immunology, 11, 723-737.

[26]   Zhaorigetu, S., Rodriguez-Aguayo, C., Sood, A.K., Lopez-Berestein, G. and Walton, B.L. (2014) Delivery of Negatively Charged Liposomes into the Atherosclerotic Plaque of Apolipoprotein E-Deficient Mouse Aortic Tissue. Journal of Liposome Research, 24, 182-190.

[27]   Zhu, Y.N., Fan, W.-J., Zhang, C., Guo, F., Li, W., et al. (2017) Role of Autophagy in Advanced Atherosclerosis (Review). Molecular Medicine Reports, 15, 2903-2908.

[28]   Sergin, I. and Razani, B. (2014) Self-Eating in the Plaque: What Macrophage Autophagy Reveals about Atherosclerosis. Trends in Endocrinology and Metabolism, 25, 225-234.

[29]   Gump, J.M. and Thorburn, A. (2011) Autophagy and Apoptosis: What Is the Connection? Trends in Cell Biology, 21, 387-392.

[30]   Eisenberg-Lerner, A., Bialik, S., Simon, H.-U. and Kimchi, A. (2009) Life and Death Partners: Apoptosis, Autophagy and the Cross-Talk between Them. Cell Death & Differentiation, 16, 966-975.

[31]   Liao, X., Sluimer, J.C., Wang, Y., Subramanian, M., Brown, K., et al. (2012) Macrophage Autophagy Plays a Protective Role in Advanced Atherosclerosis. Cell Metabolism, 15, 545-553.